| Recruiting | Intra-Hepatic Microbiota in Alcoholic Hepatitis NCT06307964 | Hospices Civils de Lyon | — |
| Recruiting | The Liver Care Trial NCT05855031 | Zealand University Hospital | N/A |
| Withdrawn | Early Detection of Alcoholic Liver Disease NCT04070508 | University of Pittsburgh | — |
| Unknown | Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY) NCT05473325 | Willows Health | — |
| Recruiting | French National MICMAF Cohort NCT05895890 | Assistance Publique - Hôpitaux de Paris | — |
| Active Not Recruiting | Alcoholic Liver Disease and the Gut Microbiome NCT05007470 | University of California, Los Angeles | N/A |
| Unknown | Gut Mycobiome Profile in Alcoholic Liver Disease. NCT05793190 | Chuncheon Sacred Heart Hospital | — |
| Recruiting | Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19 NCT04858412 | The Cleveland Clinic | N/A |
| Completed | Guselkumab (Anti-IL 23 Monoclonal Antibody) for Alcohol Associated Liver Disease NCT04736966 | University of California, San Diego | Phase 1 |
| Recruiting | Study of Alcohol-related Liver Disease in Europe NCT04400604 | University Hospital, Lille | — |
| Recruiting | Integrated Diagnostics for Early Diagnosis of Liver Disease NCT04666402 | Manchester University NHS Foundation Trust | — |
| Recruiting | Effect of Fermented Protaetia Brevitarsis Seulensis Powder on Alcohol-induced Liver Disease NCT04320199 | Pusan National University Yangsan Hospital | N/A |
| Unknown | Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of NCT04106518 | University Hospital, Lille | — |
| Completed | Integrated Approaches for Identifying Molecular Targets in Liver Disease NCT03915002 | University of Pittsburgh | — |
| Active Not Recruiting | Profermin®: Prevention of Progression in Alcoholic Liver Disease by Modulating Dysbiotic Microbiota NCT03863730 | Odense University Hospital | N/A |
| Not Yet Recruiting | Herbal Supplements for Improvement of Liver Function in Participants With Alcoholic Liver Disease NCT03503708 | Composite Interceptive Med Science | N/A |
| Terminated | Value on Survival of Liver Volume After an Acute Decompensation of an Alcoholic Cirrhosis NCT03508388 | University Hospital, Montpellier | — |
| Unknown | Stratification of Chronic Alcoholic Liver Diseases (SCALE Study) NCT03295812 | Nanfang Hospital, Southern Medical University | — |
| Active Not Recruiting | Quantitative MRI for Non-invasive Assessment of Severity of Alcoholic Liver Disease (ALD) NCT03113929 | The Cleveland Clinic | — |
| Recruiting | Evaluating Alcohol Use in Alcoholic Liver Disease NCT03267069 | Nicole T Shen | — |
| Completed | Efficacy of Antibiotic Therapy in Severe Alcoholic Hepatitis Treated With Prednisolone NCT02281929 | University Hospital, Lille | Phase 3 |
| Recruiting | Ethanol Induces Skeletal Muscle Autophagy NCT03209791 | The Cleveland Clinic | — |
| Completed | Meta-Analysis of Drug Therapy in Patients With Severe Alcoholic Hepatitis NCT02796469 | University Hospital, Lille | — |
| Completed | Long Term Effect of Aggressive Nutritional Management on Survival in Patients With Alcoholic Liver Disease NCT02140294 | Institute of Liver and Biliary Sciences, India | N/A |
| Unknown | RCT Study on Granulocyte Colony-stimulating Factor(G-CSF) Treatment of Hepatic Failure NCT02331745 | Beijing 302 Hospital | Phase 4 |
| Completed | THE IMMUNOLOGICAL EFFECTS AND METABOLIC TOLERANCE OF LIPID INFUSION IN PATIENTS WITH CIRRHOSIS. NCT02381769 | Institute of Liver and Biliary Sciences, India | N/A |
| Completed | Text Messaging to Reduce Alcohol Relapse in Liver Transplant Patients NCT03402256 | Yale University | N/A |
| Completed | Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver Disease NCT01711125 | South West Sydney Local Health District | Phase 3 |
| Unknown | Effect of Probiotics on Gut-Liver Axis of Alcoholic Hepatitis NCT02335632 | Chuncheon Sacred Heart Hospital | Phase 4 |
| Completed | A Novel Pharmacotherapy for Alcoholism and Alcohol Liver Disease NCT01504295 | Brown University | Phase 2 |
| Completed | Cognitive Function of Alcoholic Compensated Liver Cirrhosis NCT04557774 | Chuncheon Sacred Heart Hospital | — |
| Completed | Effect of Probiotics on Gut-Liver Axis of Alcoholic Liver Disease NCT01501162 | Chuncheon Sacred Heart Hospital | Phase 4 |
| Completed | FIBROSCAN Validation and Interest of Fibrotest - FIBROSCAN Association for Fibrosis Diagnosis in Alcoholic Liv NCT00708617 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | Double-blind Randomized Controlled Trial in Severe Alcoholic Hepatitis NCT01214226 | University Hospital, Lille | Phase 3 |
| Completed | Effect of Candesartan in Alcoholic Liver Fibrosis NCT00990639 | Yonsei University | Phase 1 / Phase 2 |
| Completed | Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease NCT00610597 | Erasme University Hospital | — |
| Completed | sgp130 in Chronic Human Liver Disease NCT00770198 | Erasme University Hospital | — |
| Completed | Alcohol, Gut Leakiness, & Liver Disease NCT05428072 | Rush University Medical Center | EARLY_Phase 1 |
| Completed | Influence of Adiponutrin in Chronic Liver Disease NCT01122797 | Erasme University Hospital | — |
| Completed | Role of CCL2 in Alcoholic Liver Diseases NCT01128010 | Erasme University Hospital | — |